MA
KIN

MUFG Americas’s Kindred Biosciences, Inc. KIN Stock Holding History

MUFG Americas’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-181
Closed -$2K – 1052
2017
Q4 		$2K Buy
181
+20
+12% +$156 ﹤0.01% 984
2017
Q3 		$1K Sell
161
-189
-54% -$1.42K ﹤0.01% 1104
2017
Q2 		$3K Hold
350
– – ﹤0.01% 1020
2017
Q1 		$2K Hold
350
– – ﹤0.01% 1078
2016
Q4 		$1K Sell
350
-360
-51% -$1.74K ﹤0.01% 1081
2016
Q3 		$4K Sell
710
-360
-34% -$1.52K ﹤0.01% 1016
2016
Q2 		$4K Hold
1,070
– – ﹤0.01% 1051
2016
Q1 		$4K Sell
1,070
-740
-41% -$2.61K ﹤0.01% 1011
2015
Q4 		$6K Buy
+1,810
New +$8.39K ﹤0.01% 922

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
PVAM
Pacific View Asset Management San Francisco, California $20.8M AUM 20.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MUFG Americas's KIN Position: Q1 2018 in Review

MUFG Americas sold out of Kindred Biosciences, Inc. (KIN) in Q1 2018, closing a stake of 181 shares — an estimated $2K sold.

MUFG Americas first reported a position in KIN in Q4 2015 and held it in 9 quarters. The position peaked at $6K in Q4 2015. 63 funds tracked by Wall St. Rank hold KIN as of Q1 2018.

  • MUFG Americas reported no remaining Kindred Biosciences, Inc. position as of Q1 2018 after selling out during the quarter.
  • MUFG Americas sold 181 Kindred Biosciences, Inc. shares in Q1 2018, an estimated $2K.
  • MUFG Americas first reported a position in Kindred Biosciences, Inc. in Q4 2015 and held it in 9 quarters.
  • MUFG Americas's Kindred Biosciences, Inc. position peaked at $6K in Q4 2015.
  • 63 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2018.

Based on MUFG Americas's 13F filing for Q1 2018, filed 7 May 2018.